We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About BioLumic Stock

Invest in or calculate the value of your shares in BioLumic or other pre-IPO companies through EquityZen's platform.

Get Started

BioLumic Stock

BioLumic unlocks the natural genetic potential of seeds and seedlings with specialized light treatments, data science, and technology.

About BioLumic Stock

Founded

2013

Industries

Community and Lifestyle, Science and Engineering, Agriculture and Farming

BioLumic develops light signals that activate plant growth and unlock the natural genetic potential of crops. The company's photogenics platform leverages innovation in plant science, light technology and genetic insights. Demonstrated results include higher yield, improved vigor, increased disease and pest resistance, and improvements in crops composition. These results have been across a variety of seeds and seedling: soybean, cannabis and vegetable and fruit crops. It is a clean technology that does not require the use of chemicals or amendments. BioLumic is a private company and was founded in 2013.

BioLumic Management

Leadership team at BioLumic

Chief Financial Officer

Richard Perry

R&D Lead

Scott Schaeffer

Locked Features

Join now and verify your accreditation status to gain access to:

  • BioLumic Current Valuation
  • BioLumic Stock Price
  • BioLumic Management
  • Available deals in BioLumic and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • BioLumic Cap Table and Funding History by Share Class and Liquidity Preferences
    • BioLumic Revenue and Financials
    • BioLumic Highlights
    • BioLumic Business Model
    • BioLumic Risk Factors
  • BioLumic Research Report from SACRA Research
Join Now

Trading BioLumic Stock

How to invest in BioLumic stock?

Accredited investors can buy pre-IPO stock in companies like BioLumic through EquityZen funds. These investments are made available by existing BioLumic shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell BioLumic stock?

Shareholders can sell their BioLumic stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."

More Like BioLumic